INLINE BLOOD VISCOMETER FOR CONTINUALLY MONITORING THE CIRCULATING BLOOD OF A LIVING BEING
SPECIFICATION
FIELD OF THE INVENTION
The invention pertains to methods and apparatus for measuring viscosity and more particularly, for apparatus and methods for continually detecting the viscosity of the circulating blood of a living being.
BACKGROUND OF INVENTION
The importance of determining the viscosity of blood is well-known. Fibroαen. Viscosity and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease, by Yarnell et al., Circulation, Vol. 83, No. 3, March 1991 ; Postprandial Changes in Plasma and Serum Viscosity and Plasma Lipids and Lipoproteins After an Acute Test Meal, by Tangney, et al., American Journal for Clinical Nutrition, 65:36-40, 1997; Studies of Plasma Viscosity in Primary Hyperlipoproteinaemia. by Leonhardt et al., Atherosclerosis 28, 29-40, 1977; Effects of Lipoproteins on Plasma Viscosity, by Seplowitz, et al., Atherosclerosis 38, 89-95, 1981 ; Hvperviscositv Syndrome in a Hvpercholesterolemic Patient with Primary Biliary Cirrhosis, Rosenson, et al., Gastroenterology, Vol. 98, No. 5, 1990; Blood Viscosity and Risk of Cardiovascular Events:the Edinburgh Artery Study, by Lowe et al., British Journal of Hematology, 96, 168-171 , 1997; Blood Rheoloαv Associated with Cardiovascular Risk Factors and Chronic Cardiovascular Diseases: Results of an Epidemioloαic Cross-Sectional Study, by Koenig, et al., Angiology, The Journal of Vascular Diseases, November 1988; Importance of Blood Viscoelasticitv in Arteriosclerosis, by Hell, et al., Angiology, The Journal of Vascular Diseases, June, 1989; Thermal Method for Continuous Blood-Velocitv Measurements in Large Blood Vessels, and Cardiac-Output Determination, by Delanois, Medical and Biological Engineering, Vol. 11 , No. 2, March 1973; Fluid Mechanics in Atherosclerosis, by Nerem, et al., Handbook of Bioengineering, Chapter 21 , 1985.
Much effort has been made to develop apparatus and methods for determining the viscosity of blood. Theory and Design of Disposable Clinical Blood Viscometer, by Litt et al., Biorheology, 25, 697-712, 1988; Automated Measurement of Plasma Viscosity bv Capillary Viscometer. by Cooke, et al., Journal of Clinical
Pathology 41 , 1213-1216, 1988: A Novel Computerized Viscometer/Rheometer by Jimenez and Kostic, Rev. Scientific Instruments 65, Vol 1 , January 1994; A New Instrument for the Measurement of Plasma-Viscosity, by John Harkness, The Lancet, pp. 280-281 , August 10, 1963; Blood Viscosity and Ravnaud's Disease, by Pringle, et al., The Lancet, pp. 1086-1089, May 22, 1965; Measurement of Blood Viscosity Using a Conicylindrical Viscometer, by Walker et al., Medical and Biological Engineering, pp. 551-557, September 1976.
One reference, namely, The Goldman Algorithm Revisited: Prospective Evaluation of a Computer-Derived Algorithm Versus Unaided Physician Judgment in Suspected Acute Mvocardial Infarction, by Qamar, et al., Am Heart J 138(4):705- 709, 1999, discusses the use of the Goldman algorithm for providing an indicator to acute myocardial infarction. The Goldman algorithm basically utilizes facts from a patient's history, physical examination and admission (emergency room) electrocardiogram to provide an AMI indicator.
In addition, there are a number of patents relating to blood viscosity measuring apparatus and methods. See for example, U.S. Patent Nos.: 3,342,063 (Smythe et al.); 3,720,097 (Kron); 3,999,538 (Philpot, Jr.); 4,083,363 (Philpot); 4,149,405 (Ringrose); 4,165,632 (Weber, et. al.); 4,517,830 (Gunn, deceased, et. al.); 4,519,239 (Kiesewetter, et. al.); 4,554,821 (Kiesewetter, et. al.); 4,858,127 (Kron, et. al.); 4,884,577 (Merrill); 4,947,678 (Hori et al.); 5,181 ,415 (Esvan et al.); 5,257,529 (Taniguchi et al.); 5,271 ,398 (Schlain et al.); and 5,447,440 (Davis, et. al.).
The Smythe '063 patent discloses an apparatus for measuring the viscosity of a blood sample based on the pressure detected in a conduit containing the blood sample. The Kron O97 patent discloses a method and apparatus for determining the blood viscosity using a flowmeter, a pressure source and a pressure transducer. The Philpot '538 patent discloses a method of determining blood viscosity by withdrawing blood from the vein at a constant pressure for a predetermined time period and from the volume of blood withdrawn. The Philpot "363 patent discloses an apparatus for determining blood viscosity using a hollow needle, a means for withdrawing and collecting blood from the vein via the hollow needle, a negative pressure measuring device and a timing device. The Ringrose '405 patent
discloses a method for measuring the viscosity of blood by placing a sample of it on a support and directing a beam of light through the sample and then detecting the reflected light while vibrating the support at a given frequency and amplitude. The Weber '632 patent discloses a method and apparatus for determining the fluidity of blood by drawing the blood through a capillary tube measuring cell into a reservoir and then returning the blood back through the tube at a constant flow velocity and with the pressure difference between the ends of the capillary tube being directly related to the blood viscosity. The Gunn '830 patent discloses an apparatus for determining blood viscosity that utilizes a transparent hollow tube, a needle at one end, a plunger at the other end for creating a vacuum to extract a predetermined amount and an apertured weight member that is movable within the tube and is movable by gravity at a rate that is a function of the viscosity of the blood. The Kiesewetter '239 patent discloses an apparatus for determining the flow shear stress of suspensions, principally blood, using a measuring chamber comprised of a passage configuration that simulates the natural microcirculation of capillary passages in a being. The Kiesewetter '821 patent discloses another apparatus for determining the viscosity of fluids, particularly blood, that includes the use of two parallel branches of a flow loop in combination with a flow rate measuring device for measuring the flow in one of the branches for determining the blood viscosity. The Kron '127 patent discloses an apparatus and method for determining blood viscosity of a blood sample over a wide range of shear rates. The Merrill '577 patent discloses an apparatus and method for determining the blood viscosity of a blood sample using a hollow column in fluid communication with a chamber containing a porous bed and means for measuring the blood flow rate within the column. The Hori '678 patent discloses a method for measurement of the viscosity change in blood by disposing a temperature sensor in the blood flow and stimulating the blood so as to cause a viscosity change. The Esvan '415 patent discloses an apparatus that detects the change in viscosity of a blood sample based on the relative slip of a drive element and a driven element, which holds the blood sample, that are rotated. The Taniguchi '529 patent discloses a method and apparatus for determining the viscosity of liquids, e.g., a blood sample, utilizing a pair of vertically-aligned tubes coupled together via fine tubes while using a
pressure sensor to measure the change of an internal tube pressure with the passage of time and the change of flow rate of the blood. The Bedingham '328 patent discloses an intravascular blood parameter sensing system that uses a catheter and probe having a plurality of sensors (e.g., an 02 sensor, CO2 sensor, etc.) for measuring particular blood parameters in vivo. The Schlain '398 patent discloses a intra-vessel method and apparatus for detecting undesirable wall effect on blood parameter sensors and for moving such sensors to reduce or eliminate the wall effect. The Davis '440 patent discloses an apparatus for conducting a variety of assays that are responsive to a change in the viscosity of a sample fluid, e.g., blood.
Viscosity measuring methods and devices for fluids in general are well- known. See for example, U.S. Patent Nos.: 1 ,810,992 (Dallwitz-Wegner); 2,343,061 (Irany); 2,696,734 (Brunstrum et al.); 2,700,891 (Shafer); 2,934,944 (Eolkin); 3,071 ,961 (Heigl et al.); 3,116,630 (Piros); 3,137,161 (Lewis et al.); 3,138,950 (Welty et al.); 3,277,694 (Cannon et al.); 3,286,511 (Harkness); 3,435,665 (Tzentis); 3,520,179 (Reed); 3,604,247 (Gramain et al.); 3,666,999 (Moreland, Jr. et al.); 3,680,362 (Geerdes et al.); 3,699,804 (Gassmann et al.); 3,713,328 (Aritomi); 3,782,173 (Van Vessem et al.); 3,864,962 (Stark et al.); 3,908,441 (Virloget); 3,952,577 (Hayes et al.); 3,990,295 (Renovanz et al.); 4,149,405 (Ringrose); 4,302,965 (Johnson et al.); 4,426,878 (Price et al.); 4,432,761 (Dawe); 4,616,503 (Plungis et al.); 4,637,250 (Irvine, Jr. et al.); 4,680,957 (Dodd); 4,680,958 (Ruelle et al.); 4,750,351 (Ball); 4,856,322 (Langrick et al.); 4,899,575 (Chu et al.); 5,142,899 (Park et al.); 5,222,497 (Ono); 5,224,375 (You et al.); 5,257,529 (Taniguchi et al.); 5,327,778 (Park); and 5,365,776 (Lehmann et al.).
The following U.S. patents disclose viscosity or flow measuring devices, or liquid level detecting devices using optical monitoring: U.S. Patent Nos. 3,908,441 (Virloget); 5,099,698 (Kath, et. al.); 5,333,497 (Br nd Dag A. et al.). The Virloget '441 patent discloses a device for use in viscometer that detects the level of a liquid in a transparent tube using photodetection. The Kath '698 patent discloses an apparatus for optically scanning a rotameter flow gauge and determining the position of a float therein. The Br nd Dag A. '497 patent discloses a method and
apparatus for continuous measurement of liquid flow velocity of two risers by a charge coupled device (CCD) sensor.
U.S. Patent No. 5,421 ,328 (Bedingham) discloses an intravascular blood parameter sensing system.
A statutory invention registration, H93 (Matta et al.) discloses an apparatus and method for measuring elongational viscosity of a test fluid using a movie or video camera to monitor a drop of the fluid under test.
The following publications discuss red blood cell deformability and/or devices used for determining such: Measurement of Human Red Blood Cell Deformability Using a Single Micropore on a Thin Si3^ Film, by Ogura et al, IEEE Transactions on Biomedical Engineering, Vol. 38, No. 8, August 1991 ; the Pall BPF4 High Efficiency Leukocyte Removal Blood Processing Filter System, Pall Biomedical Products Corporation, 1993.
A device called the "Hevimet 40" has recently been advertised at www.hevimet.freeserve.co.uk. The Hevimet 40 device is stated to be a whole blood and plasma viscometer that tracks the meniscus of a blood sample that falls due to gravity through a capillary. While the Hevimet 40 device may be generally suitable for some whole blood or blood plasma viscosity determinations, it appears to exhibit several significant drawbacks. For example, among other things, the Hevimet 40 device appears to require the use of anti-coagulants. Moreover, this device relies on the assumption that the circulatory characteristics of the blood sample are for a period of 3 hours the same as that for the patient's circulating blood. That assumption may not be completely valid.
Notwithstanding the existence of the foregoing technology, there remains a need for an inline blood viscometer that provides for the continuous monitoring of the viscosity of the circulating blood of a living being that may be undergoing a surgical procedure, and where it is critical for the surgeon to know the living being's most current blood viscosity.
SUMMARY OF THE INVENTION
An apparatus for continuously determining the viscosity of the circulating blood of a living being over plural shear rates using a decreasing pressure differential.
A method for continuously determining the viscosity of the circulating blood of a living being over plural shear rates using a decreasing pressure differential.
DESCRIPTION OF THE DRAWINGS
Fig. 1 is a diagrammatic view of the inline blood viscometer depicting a first column of blood being generated therein;
Fig. 2 is a diagrammatic view of the inline blood viscometer depicting a second column of blood being generated therein;
Fig. 3 is a diagrammatic view of the inline blood viscometer depicting the two columns of blood being placed into fluid communication with each other;
Fig. 4 is a diagrammatic view of the inline blood viscometer depicting how the flow restrictor path is rinsed and dried after a test run;
Fig. 5 is a diagrammatic view of the inline blood viscometer depicting how the riser tubes are rinsed and dried after a test run; and
Fig. 6 is a graphical representation of the height of the respective columns of blood over time in the riser tubes.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring now in detail to the various figures of the drawing wherein like reference characters refer to like parts, there is shown at 20 in Fig. 1 an inline blood viscometer for continually monitoring the circulating blood of a living being. The terms "continually" and "continuous" as used throughout this Specification means that once the apparatus 20 is coupled to the vascular system of the living being, the viscosity of the circulating blood can be repeatedly determined over time without human intervention.
The inline blood viscometer 20 basically comprises a pair of riser tubes, R1 and R2 that are coupled at their lower ends via respective valves, valve A and valve B, to a flow restrictor 52 (e.g., a capillary tube). As will be described in detail later, the circulating blood of the living being is diverted into this structure and respective columns of blood are formed in the two riser tubes R1 and R2. A decreasing pressure differential then causes the columns of blood to move in opposite directions through a plurality of shear rates, as the column of blood 82 in one riser tube (e.g., R1 ) falls and passes through the flow restrictor 52 which causes the column of blood 84 (Fig. 2) in the other riser tube, R2, to move upward. This
movement of the columns of blood through a plurality of shear rates, along with the dimensions of the flow restrictor 52 and the riser tubes R1 and R2, are then used to calculate the viscosity of the circulating blood.
The operation of the inline blood viscometer 20 is similar to the dual riser/single capillary (DRSC) viscometer as described in A.S.N. 09/573,267, filed May 18, 2000, and A.S.N. 09/439,795 filed November 12, 1999, both entitled DUAL RISER/SINGLE CAPILLARY VISCOMETER, both assigned to the same Assignee as the present invention, namely Visco Technologies, Inc., and both of whose entire disclosures are incorporated by reference herein. The viscometers disclosed in those patent applications are also referred to as "circulating blood viscometers." The DRSC viscometer also includes a pair of riser tubes and a flow restrictor (e.g., a capillary tube) and utilizes a decreasing pressure differential to subject a pair of oppositely moving columns of fluid to move through a plurality of shear rates. The movement of these oppositely-moving columns is monitored over time to generate data related to these moving columns. This data, along with the dimensions of the flow restrictor and the riser tubes, are used to calculate the viscosity of the fluid.
In particular, as shown in Fig. 1 , the inline blood viscometer 20 comprises the riser tubes R1 and R2. The upper ends of the riser tubes R1 and R2 are coupled together through a conduit 22 which includes a valve C that can vent to the atmosphere. The lower end of riser tube R1 is coupled to valve A and the lower end of riser tube R2 is coupled to valve B. The flow restrictor 52 is coupled between valves A and B through a fourth valve D. Circulating blood from the blood vessel of the living being is inputted to the inline blood viscometer 20 through the input to valve A. Once the viscosity test is completed, the blood is discarded and the flow restrictor 52 path and the riser tubes R1 and R2 are rinsed (e.g., using a rinse pump 24) and then dried (e.g., using a dryer 29) in preparation for the next viscosity test run; this last step is important to move any residue (e.g., aggregated blood, coagulated blood, etc.) in these components and to dry them before the next viscosity test run. Furthermore, to monitor the changing columns of blood in the riser tubes R1 and R2, column level detectors 54 and 56 are provided. These column level detectors 54/56 are by way of example only and any method for detecting the changing height of the columns of blood 82/84 over time in the
respective riser tubes R1 and R2 are contemplated by Applicants; this includes using mass detection (i.e., the changing mass in each of the riser tubes R1 and R2) as well as time of flight detection (using sound waves, including ultrasound, to monitor the level of each of the columns 82/84 over time). The details of the column level detectors 54 and 56 are provided in A.S.N. 09/439,795 and A.S.N. 09/573,267 and are not repeated here.
Although not shown, a computer (e.g., a "386" microprocessor or greater, or microcontroller or any equivalent) controls the valves A-D. In addition, the column level detectors 54/56 are also electrically coupled to the computer (also referred to as "processor") to provide the changing column height data to the computer for calculating the viscosity of the circulating blood. In addition, although not shown, the computer may comprise a monitor or panel for displaying the calculated viscosity value and other related data and/or this information can be provided to remote locations (e.g., printers, dataloggers, other computers) via global communication networks, e.g., the Internet.
It should be understood that although it is preferable to have each riser tube R1 and R2 in a vertical position, it is within the broadest scope of this invention to have the riser tubes R1 and R2 oriented at any angle, greater than zero degrees, with respect to a horizontal reference.
It should also be understood that modifying these circulating blood viscometers to include the conduit 22 and the valves A - D, the DRSC viscometer becomes a "closed-system" which permits the apparatus 20 to run automatically and which can be automatically rinsed and dried in preparation for the next viscosity determination run, and hence the "continuous" operation thereof.
The operation of the inline blood viscometer 20 is as follows: The blood vessel of the living being is coupled (e.g., a catheter, not shown) to the input of valve A which is positioned as shown in Fig. 1. As a result, the circulating blood of the living being is diverted into the inline blood viscometer 20 to form the column of blood 82 in riser tube R1. When the column of blood 82 reaches a predetermined height, h1i; that is detected by the column level detector 54, the computer drives valves A and B into the positions shown in Fig. 2. This diverts the circulating blood through the flow restrictor 52, through valves D and B and up into riser tube R2 to
form the second column of blood 84. When a predetermined height (different from hn) of the column of blood 84 is detected by the column level detector 56, a pressure differential is created between the column of fluid 82 and the column of fluid 84. The computer then drives valves A and C into the positions shown in Fig. 3. This action couples the two columns of blood 82 and 84 together through the flow restrictor 52 while cutting off the vent to atmosphere. The result of this action is that the column of blood 82 in riser tube R1 falls (see direction of arrow 31 ) while the column of blood 84 in riser tube R2 rises (see direction of arrow 33). As the column of blood 82 moves downward and the column of blood 84 moves upward, this movement causes the pressure differential to decrease, thereby causing the movement of the two columns 82/84 to slow down. The column level detectors 54/56 monitor the changing heights of the respective columns of blood 82/84 and provide that data to the computer (see Fig. 5). As discussed in detail in A.S.N. 09/573,267 and A.S.N. 09/439,795, the final levels of the columns of blood 82/84, namely, h^∞) and h2(∞), respectively, are separated by a Δh(∞). This separation of the column heights can be attributed to surface tension, Δhst and/or yield stress, τy , of the blood. As can be seen most clearly in Fig. 2, the presence of the
gas/fluid interface 85 for both columns of blood 82/84 accounts for the surface tension. As will be discussed later, a method for isolating the effects of surface tension Δhst and yield stress τ is also incorporated into the apparatus/method of
the present invention 20.
Once the Δh(∞) is detected, the viscosity test run is complete and the computer calculates the viscosity of the circulating blood based on the changing height data (h^t), h2(t), Δh(t)) along with the dimensions of the flow restrictor 52 and the riser tubes, R1/R2. At the same time, the computer then commands valves A - D to assume the positions shown in Fig. 4, while energizing the rinsing pump 24 (e.g., a miniature solenoid micro pump such as those sold by Bio-Chem Valve, Inc., of Boonton, NJ). The result of this action is to provide a rinsing and drying path for the flow restrictor 52 in order to discard the blood in the lower path by rinsing it with an IV solution and then drying that path using the dryer 29 (e.g., GCHIS-C05/120V small capacity/low flow heater by Omega Engineering of Stamford, CT). In
particular, with the rinsing pump 24 activated and with valve A rotated as shown in Fig. 4, the input path from the vascular system of the living being is isolated while the blood in the flow restrictor 52 path is driven through valve B to be discarded (e.g., into a collector, drain, etc.); with valve C venting to atmosphere, the blood in the flow restrictor 52 path can be easily removed. The computer then de-activates the rinsing pump 24 and activates the dryer 29 for introducing hot air to dry the flow restrictor 52 path using the same valve positions. It should be noted that during rinsing, the dryer 29 acts merely as a conduit of the IV solution; conversely, when the dryer 29 is activated, no IV solution is passed to the dryer 29 from the rinsing pump 24. Next, the computer commands valves A - D into the positions shown in Fig. 5 in order to rinse/dry the riser tubes R1 and R2 through the conduit 22; the rinsing pump 24 and dryer 29 operate similarly as discussed with regard to the flow restrictor 52 path.
Once the riser tubes R1/R2 and conduit 22 are rinsed and dried, the computer de-activates the dryer 29 and commands valves A - D into the positions shown in Fig. 1 to prepare for a new set of columns of blood to be generated. Thus, the process is continuously repeated: diverting circulating blood into the inline blood viscometer 20 and establishing the oppositely moving columns of blood 82/84 which are then monitored, data generated and from which the blood viscosity is then determined, and then rinsing/drying the two paths.
As stated in A.S.N. 09/439,795, there are a plurality of mathematical models that can be used as curve fitting models for the data obtained from the DRSC viscometer such as a power law model, a Casson model, a Carreau model, a Herschel-Bulkley model, a Powell-Eyring model, a Cross model, Carreau-Yasuda model. It is within the broadest scope of this invention 20 to also include all of these models. The following discussion utilizes a power law model and is used by way of example only and not by way of limitation. Thus, one skilled in the art could substitute any of the above curve fitting models for the exemplary power law model discussed below
In particular, for non-Newtonian fluids, as is blood, the viscosity varies with shear rate, however, Hagen-Poiseuille flow within the capillary still holds for steady or quasi-steady laminar flow. For a fluid that is well-correlated with a non-
Newtonian power law viscosity model, the capillary pressure drop and flow rate are related as follows:
where the shear rate, γ is related to the capillary flow rate by:
where the power law viscosity is defined as:
ΔPC = capillary tube pressure drop (Pa)
Lc = length of capillary tube (m)
Q = volumetric flow rate (m3/s) k = consistency index (a constant used in capillary viscometry) - that is determined; n = power law index (another constant used in capillary viscometry) -that is determined; φc = capillary tube diameter (m) μ = fluid viscosity (centipoise, CP) γ = shear rate (s"1)
Since blood, a non-Newtonian fluid, is well-characterized with a power law viscosity model, Equation (1) can be re-written as:
where p - blood fluid density; g = gravitational constant; h1 = instantaneous height of the column of blood in riser R1 h2 = instantaneous height of the column of blood in riser R2 φc = inside diameter of the capillary tube φr = inside diameter of riser tube and where φc «< φr
Δhst = an offset in column heights due to surface tension and/or yield stress τy of the blood.
It should be noted that the length of the capillary tube Lc is assumed large such that any friction forces in the riser tubes R1 and R2 and connecting fluid components can be ignored. In addition, the diameter of the riser tubes R1 and R2 are equal. By integrating both sides of Equation (4) with respect to time, the need to dh determine—— is eliminated, which yields: at
where h0 = h1(t) - h2(t) at t=0; i.e., h0 = hιr h2i; and
In order to determine the viscosity, it is necessary to determine the values for k and n using curve fitting based on the test run data. In particular, the following procedure is used:
1) Conduct a test run and obtain all h^t) and h2(t) data;
2) Fit curves through the data to obtain symbolic expressions for h^t) and h2(t);
3) Determine all h^t) - h2(t) data, as well as Δhst;
3) Assume values for the power law parameters k and n;
4) Calculate the following error values for all data points:
6) Sum the error values for all data points;
7) Iterate to determine the values of k and n that minimize the error sum; and
8) Use the determined k and n values in Equations (2) and (3) to calculate viscosity.
As mentioned earlier, the apparatus and method of the present invention 20 also incorporates a method of isolating surface tension (Δhst) and yield stress ( τy )effects as set forth in A.S.N. 09/708,137 filed on November 8, 2000 entitled
Method of Isolating Surface Tension & Yield Stress in Viscosity Measurements and which is assigned to the same Assignee as the present invention, namely Visco Technologies, Inc. Thus, the entire disclosure of A.S.N. 09/708,137 is incorporated by reference herein. As described in detail therein, the method basically comprises defining an expression for the pressure drop across the flow restrictor 52, in terms of the height of the columns of blood as: Pc(t) = giMt) - h2(t) - Ahst] (8) where Δhst represents the height difference between the two columns of blood due to surface tension. The method also further comprises defining the yield stress of the blood as:
where ΔP(∞) is evaluated at t=∞ using Equation 8.
The method uses two alternative approaches for solving for Δhst and τy and
thereby provides a mechanism for isolating the effects of these two components on the blood viscosity determination.
It should be understood that the pressure differential created between the columns of blood 82/84, pgΔh, where p is the density of the blood, ignores the density of the gas (e.g., air) that is trapped in the conduit 22 since the density of the gas is significantly smaller in comparison to the blood density.
It should be further noted that the conduit 22, the riser tubes R1/R2, the valves A-D, the pump 24 are all disposable as a set. Thus, when a new patient is to be coupled to the inline blood viscometer 20, a new set can be inserted.
As with the devices disclosed in A.S.N. 09/573,267 and A.S.N. 09/439,795, although the riser tubes R1 and R2 are shown in vertical orientations, these riser tubes R1 and R2 could be positioned in at any angle greater than zero degrees with respect to a horizontal reference, e.g., the datum line.
It should be understood that, as explained in A.S.N. 09/573,267, due to the symmetry of the height vs. time data (see Fig. 6) for each of the columns of blood that move in the respective riser tubes, R1 and R2, it is not necessary to monitor both columns as they move; instead, only one column needs to be monitored over time while a single data point from the other column need only be taken. Thus, either column level detector 54 or 56 can be replaced by a single point detector; as further discussed in A.S.N. 09/573,267, it is preferable to monitor over time, the changing column level of the rising column while detecting a single data point from the falling column.
Without further elaboration, the foregoing will so fully illustrate our invention that others may, by applying current or future knowledge, readily adopt the same for use under various conditions of service.